Polyvalent vaccination against hepatitis B surface and core antigen using a dicistronic expression plasmid

By Wild J.   Gruner B.   Metzger K.   Kuhrober A.   Pudollek H.-P.   Hauser H.   Schirmbeck R.   Reimann J.  

Vaccine, Vol. 16, Iss. 4, 1998-02 ,pp. : 353-360

Elsevier

Access to resources Recommend Favorite

Vaccination against Schistosoma mansoni infection using 74 kDa Schistosoma protein antigen

By Attallah A.M.   Attia H.   Ismail H.   Yones E.   El-Nashar E.M.   Abd El-Kader K.   Tabll A.   Saad A.   Sultan A.  

Vaccine, Vol. 17, Iss. 22, 1999-07 ,pp. : 2786-2791

Elsevier

Access to resources Recommend Favorite

DNA vaccination with the immunodominant tachyzoite surface antigen (SAG-1) protects against adult acquired Toxoplasma gondii infection but does not prevent maternofoetal transmission

By Couper K.N.   Nielsen H.V.   Petersen E.   Roberts F.   Roberts C.W.   Alexander J.  

Vaccine, Vol. 21, Iss. 21, 2003-06 ,pp. : 2813-2820

Elsevier

Access to resources Recommend Favorite

Vaccination with recombinant Parasite Surface Antigen 2 from Leishmania major induces a Th1 type of immune response but does not protect against infection

By Sjolander A.   Baldwin T.M.   Curtis J.M.   Bengtsson K.L.   Handman E.  

Vaccine, Vol. 16, Iss. 20, 1998-12 ,pp. : 2077-2084

Elsevier

Access to resources Recommend Favorite

Immunization against Plasmodium chabaudi malaria using combined formulations of apical membrane antigen-1 and merozoite surface protein-1

By Burns J.M.   Flaherty P.R.   Romero M.M.   Weidanz W.P.  

Vaccine, Vol. 21, Iss. 17, 2003-05 ,pp. : 1843-1852

Elsevier

Access to resources Recommend Favorite